Literature DB >> 8879988

The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action.

P F Collett-Solberg1, P Cohen.   

Abstract

Over the past few years, there has been an explosion of data in the scientific literature regarding the various components of the IGF axis. IGFBPs and related molecules are now believed to be critical elements in numerous cellular processes and key factors in several disease states related to abnormal tissue and somatic growth. Recently, the BP-Prs were included in this complex system, and their importance is being unraveled. The upcoming years will undoubtedly bring even more information on the molecular biology of these key cellular regulators. These discoveries are likely to lead to better understanding of growth and cellular regulation and to development of novel therapeutic approaches to a variety of diseases.

Mesh:

Substances:

Year:  1996        PMID: 8879988     DOI: 10.1016/s0889-8529(05)70342-x

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  31 in total

1.  Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways.

Authors:  M A Lawlor; X Feng; D R Everding; K Sieger; C E Stewart; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 2.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

3.  Is the measurement of free IGF-I more indicative than that of total IGF-I in the evaluation of the biological activity of the GH/IGF-I axis?

Authors:  J A Janssen; S W Lamberts
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 4.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

Review 5.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

6.  Insulin-like growth factor-binding protein 4 in children with acute lymphoblastic leukemia.

Authors:  Heike Wex; Dörte Ahrens; Bianka Hohmann; Antje Redlich; Uwe Mittler; Peter Vorwerk
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

7.  Phytanic acid attenuates insulin-like growth factor-1 activity via nitric oxide-mediated γ-secretase activation in rat aortic smooth muscle cells: possible implications for pathogenesis of infantile Refsum disease.

Authors:  Gursev S Dhaunsi; Mayra Alsaeid; Saghir Akhtar
Journal:  Pediatr Res       Date:  2016-11-25       Impact factor: 3.756

8.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

Authors:  David J Degraff; Adam A Aguiar; Robert A Sikes
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

9.  Acute hormonal responses of a high impact physical exercise session in early postmenopausal women.

Authors:  W Kemmler; L Wildt; K Engelke; R Pintag; M Pavel; B Bracher; J Weineck; W Kalender
Journal:  Eur J Appl Physiol       Date:  2003-07-09       Impact factor: 3.078

10.  The insulin-like growth factor system and its receptors: A potential novel anticancer target.

Authors:  Colin R Lindsay; Tr Jeffry Evans
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.